A Phase I Study of SHR-3836 in Patients With Multiple Myeloma

Clinical trial NCT07490613 · RECRUITING

Trial details

NCT number: NCT07490613
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2026-06-02
Primary completion: 2028-04-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.